ArticleBMC veterinary research2025
P1PK blood group antigens in birds: implications for veterinary blood transfusion, human and pet health.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundThe P1PK blood group system in humans, composed of three glycosphingolipid antigens, plays a significant role in transfusion medicine. These antigens are synthesized by the enzyme α1,4-galactosyltransferase, encoded by the A4GALT gene, and also act as receptors for Shiga toxins, which are key virulence factors produced by pathogenic strains of Escherichia coli. Birds are known to be resistant to the effects of Shiga toxins, yet the molecular basis of this resistance has remained unclear. This study aimed to investigate the presence, expression, and functional role of P1PK antigens in birds, particularly in relation to their exposure to human-associated bacteria.
resultsBirds residing in urban environments, such as pigeons (Columba livia) and crows (Corvus cornix), express higher levels of Shiga toxin receptors on their red blood cells. These levels are higher compared to species living in more isolated areas, such as woodcocks (Scolopax rusticola). This pattern may suggest an evolutionary adaptation to human environments. We analyzed RBC glycan expression in 52 birds representing 10 species using flow cytometry, mass spectrometry, and HPTLC to assess interspecies variation in P1PK-related antigens. We propose that the increased expression of these antigens in urban birds functions as a decoy mechanism, reducing the toxicity of Shiga toxins by sequestering them before they can cause cellular damage. The glycomic analysis identified novel glycosphingolipids and glycoproteins with terminal galactose residues that are specifically recognized by the B subunit of Shiga toxin. In addition, we found that a cellular protein, RAB11FIP5, may influence the intracellular trafficking of Shiga toxins, adding another layer of protection in birds.
conclusionsOur data suggests that certain birds, particularly those residing in human-influenced environments, possess mechanisms that enable them to partially tolerate or neutralize Shiga toxins. These findings provide a basis for comparative studies of avian red blood cell glycan biology and offer valuable context for future research in veterinary transfusion science and immunology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.